Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02866877 · ClinicalTrials.gov registry record
Effects of Augmented Renal Clearance on Pharmacokinetic and Pharmacodynamic Properties of Levetiracetam in Subarachnoid Hemorrhage
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 15
- Enrollment target
NCT02866877: Completed study, sponsored by University of Colorado, Denver.
NCT02866877 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02866877 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
This study evaluates the pharmacokinetic profile of levetiracetam in critically ill patients who have suffered a subarachnoid hemorrhage. The patients will be evaluated for development of augmented renal clearance and the effects and duration of effects this may have on levetiracetam clearance.
Primary Outcome
calculated systemic levetiracetam clearance (based on plasma concentrations) within 48 hours of initial presentation to the neurointensive care unit and every 5 days thereafter up to 20 days
Interventions
- OTHER Pharmacokinetic modeling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2016-01 |
| Est. Completion | 2021-03 |
What the finished NCT02866877 record still lists
NCT02866877 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Pharmacokinetic modeling is the first listed.
NCT02866877 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02866877 about?
NCT02866877 is a clinical study titled "Effects of Augmented Renal Clearance on Pharmacokinetic and Pharmacodynamic Properties of Levetiracetam in Subarachnoid Hemorrhage". This study evaluates the pharmacokinetic profile of levetiracetam in critically ill patients who have suffered a subarachnoid hemorrhage. The patients will be evaluated for development of augmented renal clearance and the effects and duration of effects this may have on levetiracetam clearance.
What is the current status of trial NCT02866877?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2016-01. Estimated completion is 2021-03.
What interventions are being tested in trial NCT02866877?
The interventions under investigation include: Pharmacokinetic modeling (OTHER).
Who is sponsoring clinical trial NCT02866877?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia